← Eichor
Study identifier: NCT07174102 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography

Condition: Reumatoid Arthritis · Interstitial Lung Disease Due to Systemic Disease (Disorder) · Idiopathic Pulmonary Fibrosis (IPF)  ·  Sponsor: Azienda Unita Sanitaria Locale di Piacenza

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Lung involvement is one of the most frequent extra articular involvements of rheumatoid arthritis (RA). RA related lung involvement can affect parenchyma, airway, vascular tree and serosa. Among all possible manifestations of lung disease, interstitial lung disease is the most severe being able to compromise quality of life and survival and involves about 20% of patients with rheumatoid arthritis (RA). However, chest high resolution computed tomography (HRCT) features of RA, with or without interstitial lung involvement, have not been clearly defined. Such features have been mostly investigated on small populations of RA patients, often including patients with connective tissue diseases (CTDs), namely systemic sclerosis, mixed connective tissue disease, idiopathic inflammatory myopathies, making difficult to discriminate possible specific features of RA interstitial lung disease (ILD). The aims of this observational longitudinal study are to investigate: i) chest HRCT features of RA (frequency of radiologic HRCT patterns, fibrosis, nodules, bronchiectasis, etc.), associated or not to ILD; ii) possible associations between chest HRCT features and demographic, clinical and serologic characteristics of RA; iii) specific chest HRCT features of RA ILD, compared to idiopathic pulmonary fibrosis (IPF) and CTD ILD (i.e., primary Sjogren syndrome, idiopathic inflammatory myopathies, etc), according to the Centres availability. Consecutive, unselected, DICOM files of chest HRCT of ad…

This description comes directly from the study's public registry record.

Talk to the study team

Marco Sebastiani, MD  ·  +39 0523302645  ·  m.sebastiani@ausl.pc.it

Francesca Cozzini, M.D.  ·  +39 0523302645  ·  f.cozzini@ausl.pc.it

Always discuss trial participation with your own doctor first.

Locations (5)

Institute of Rheumatology, Na Slupi 4Prague, CzechiaNot Yet Recruiting
UOC Reumatologia, Arcipedale Sant'AnnaFerrara, ItalyRecruiting
SC Malattie Apparato Respiratorio, Azienda Policlinico di ModenaModena, ItalyRecruiting
Local Health Unit ("Azienda Unità Sanitaria Locale", AUSL) of PiacenzaPiacenza, ItalyRecruiting
AUSL-IRCCS di Reggio EmiliaReggio Emilia, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07174102